July 2008 Volume 4, Issue 7
Volume 4, Issue 7 | July 2008
July 2008
In this Issue
Research & Development
Upping the antibody ante
Novartis buys Protez in deal worth up to $400 millionOh la la! Ipsen goes wild
French pharma expands global footprint with three U.S. deals totaling $450MWanted: CNS disorder drugs
Roche, PsychoGenics team up to identify neuropsyciatric disorder treatmentsPink slips pile up
GSK axes 350 R&D jobsLocus furthers cancer focus
Locus inks cancer research deals with two academic centersGlobal News
Big pharma goes generic
Daiichi Sankyo to take control of Ranbaxy in $4.6 billion dealBidding for generic stake?
Sanofi-aventis, PPF on verge of bidding war for Czech generic drug maker ZentivaCytRx to acquire Innovive
$23 million deal creates company focused on molecular chaperone technology platform, near-term oncology opportunitiesProducing purified plasmid DNA
Boehringer Ingelheim and GENEART to offer design and production services for DNA therapeutics, vaccinesSymphogen in infectious disease collaboration with Genentech
Symphogen A/S announced it entered a global strategic collaboration with Genentech Inc. for antibody therapeutics against three undisclosed infectious disease targets.Genomics & Proteomics
Here we genome again
The Human Microbiome Project, dubbed the ‘Second Human Genome Project,’ poses more complexitiesKiller turned savior
Insights into Huntington’s protein lead to major discovery for vaccine adjuvantsU.S. provides personal touch
TGen, PPM and ISB team up to help Luxembourg harness genomics and proteomics techThree\'s company
1000 Genomes Project welcomes Illumina, Applied Bio and 454Informatics
Attractive acquisition
Parexel makes $182M offer for ClinPhoneOne platform for MS research
MRF taps CDD’s Web-based software to integrate MS research effortsRise of Phenyx
GeneBio marries Phenyx platform with Nonlinear’s Progenesis MS softwareOpen biology
NextBio expands search engine and launches free public accessPutting teeth into bioinformatics
Waters, Rosetta extend proteomic research collaborationLinguamatics joins Microsoft BioIT Alliance
Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.Commentary
What’s new can be old in life sciences
When you’ve been around the block a few times, you start to recognize familiar landmarks. When you are young, perspective is harder, but it’s not disabling, either.Editor's Focus
A generic tale: Go east, young man!
With apologies to the 19th century New York Tribune editor, Horace Greeley, the phrase "go west, young man!" can now be turned around for life sciences and pharmaceutical companies looking for opportunity at the beginning of this millennium.Automation & Instrumentation
Invitrogen, Applied Bio to merge
Invitrogen ponies up $6.7 billion in cash and stock to create a life sciences juggernautA cultural connection
Thermo Fisher reaches across all divisions to create the Cell Culture Excellence ProgramCovering the sample prep bases
Leica Microsystems acquires Bal-Tec to provide complete sample prep offering for microscopy
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
